Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 3412 (114th)

Ban Poisonous Additives Act of 2016

referredUnited States· United States Congress· EN

Introduced

28 September 2016

Last action

28 September 2016 · Introduced

Status

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsors

Sen. Markey, Edward J. [D-MA]

Subjects

Healthcare, Environment

Source updated

5 December 2025

Healthcare · Environment

Summary

Ban Poisonous Additives Act of 2016 This bill bans food containers composed, in whole or in part, of bisphenol A (BPA). The Food and Drug Administration (FDA) may grant waivers to a facility for a particular product if the facility: (1) demonstrates that it is not technologically feasible to replace BPA in the container or to use a BPA-free container, and (2) submits to the FDA a plan and time line for removing BPA from the container. Products granted a waiver must include a warning on the label. The FDA must promote and facilitate the use of BPA replacements. BPA may not be replaced with substances that: (1) are known or likely human carcinogens; (2) have been found by the Environmental Protection Agency (EPA) to be persistent, bioaccumulative, and toxic; (3) cause reproductive or developmental toxicity; or (4) are endocrine disrupting chemicals. The FDA must review substances that may be found in food, including food additives and food contact substances, and take remedial action if it does not determine that there is a reasonable certainty that no harm will result from aggregate exposure, taking into consideration potential adverse effects from low-dose exposure and the effects on vulnerable populations and populations with high exposure. This bill amends the Federal Food, Drug, and Cosmetic Act to require the manufacturer or supplier of a food contact substance to notify the FDA of the identity and intended use of the substance prior to its introduction into interstate commerce and that: (1) no adverse health effects result from low-dose exposures to the substance, and (2) the substance has not been shown to cause reproductive or developmental toxicity in humans or animals.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 28 September 2016

    Introduced

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Source: IntroReferral

  2. 28 September 2016

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 28 September 2016

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 28 September 2016

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 28 September 2016

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.